MOUNTAIN VIEW, Calif., Jan. 12 /PRNewswire/ -- Concentric Medical, Inc., the global leader in acute ischemic stroke intervention, today announced that the first cases have been performed using its Trevo(TM) System in Europe. The Trevo System is an innovative, high performing, easy-to-use thrombus retrieval system. The main component of the Trevo System is a stentriever(TM), a new generation of retrieval devices which removes clots that cause stroke.
Concentric Medical is the pioneer in developing devices for ischemic stroke intervention. Since 2004, Concentric Medical’s devices have been used in thousands of stroke patients worldwide. This experience has been incorporated into the design of the Trevo System to make thrombus removal an easier, faster and more predictable procedure.
Concentric Medical currently markets the Merci Retriever(R), which is the market leading solution for ischemic stroke intervention. In addition, Concentric’s DAC(TM) catheters are often used in the setting of ischemic stroke and other neurointerventional procedures. Together, the Trevo System, the Merci Retriever and the DAC family of catheters represent an unparalleled array of choices for physicians involved in the treatment of ischemic stroke.
About Acute Ischemic Stroke
Stroke is the third leading cause of death in the developed world and the leading cause of serious long-term disability. Ischemic stroke represents over 85% of strokes and occurs when a blockage or clot develops in one of the arteries supplying blood to the brain. In 2004 the FDA cleared Concentric Medical’s Merci Retriever for use in patients who are ineligible for IV-tPA or who fail to respond to IV-tPA therapy. This pioneering device created a departure from the historic method of caring for stroke patients and offered physicians and patients a long-awaited option for stroke intervention.
Concentric Medical
